Immuneering (IMRX) Cash from Financing Activities (2020 - 2026)
Immuneering (IMRX) posted Cash from Financing Activities of $220,174 for Q3 2026, down 99.9% from $213.19 million a year earlier but up 794.7% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Cash from Financing Activities (2020 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Cash from Financing Activities at Immuneering was $68,019, down 100.0% year-over-year; for FY2025, it came in at $226.58 million.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of 42.9% (FY2020 to FY2025).
- In prior years, Immuneering's Cash from Financing Activities was $5.3 million in FY2024 (-81.4%), $28.44 million in FY2023, $19,004 in FY2022 (-100.0%) and $144.26 million in FY2021 (+279.8%).
- Quarterly Cash from Financing Activities has run from a low of -$357,523 in Q4 2025 to a high of $213.19 million in Q3 2025 over five years.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was $24,608 (Q2 2026), $180,760 (Q1 2026) and -$357,523 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.51 Bn |
| 10 | Immuneering | 249.34 Mn | -375.49 Mn | - | 220,174.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 220,174.00 |
| Jun 30, 2026 | 24,608.00 |
| Mar 31, 2026 | 180,760.00 |
| Dec 31, 2025 | -357,523.00 |
| Sep 30, 2025 | 213.19 Mn |
| Jun 30, 2025 | -61,958.00 |
| Mar 31, 2025 | 13.81 Mn |
| Dec 31, 2024 | -40,988.00 |
| Sep 30, 2024 | 4.36 Mn |
| Mar 31, 2024 | 979,923.00 |
| Dec 31, 2023 | 7,835.00 |
| Sep 30, 2023 | 21,448.00 |
| Jun 30, 2023 | 28.17 Mn |
| Mar 31, 2023 | 239,408.00 |
| Dec 31, 2022 | -184,677.00 |
| Sep 30, 2022 | -17,214.00 |
| Jun 30, 2022 | 27,784.00 |
| Mar 31, 2022 | 193,111.00 |
| Dec 31, 2021 | 7,519.00 |
| Sep 30, 2021 | 118.49 Mn |
API Access
Immuneering Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();